NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.01024.a: Enolase (MG_407)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: target approved
center reference id: MygeA.01024.a
is community request: True
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Molecular models

Method Results
comparative modelling Robetta_81182

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.476
UniProt: P47647

Enzyme & Pathway Information

Pathway Pathway ID EC Number
homolactic fermentation ANAEROFRUCAT-PWY 4.2.1.11
glycolysis III (from glucose) ANAGLYCOLYSIS-PWY 4.2.1.11
respiration (anaerobic) ANARESP1-PWY 4.2.1.11
gluconeogenesis I GLUCONEO-PWY 4.2.1.11
glycolysis I (from glucose 6-phosphate) GLYCOLYSIS 4.2.1.11
superpathway of glycolysis and the Entner-Doudoroff pathway GLYCOLYSIS-E-D 4.2.1.11
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass GLYCOLYSIS-TCA-GLYOX-BYPASS 4.2.1.11
superpathway of hexitol degradation (bacteria) HEXITOLDEGSUPER-PWY 4.2.1.11
Entner-Doudoroff pathway II (non-phosphorylative) NPGLUCAT-PWY 4.2.1.11
heterolactic fermentation P122-PWY 4.2.1.11
Bifidobacterium shunt P124-PWY 4.2.1.11
glycolysis V (Pyrococcus) P341-PWY 4.2.1.11
superpathway of N-acetylneuraminate degradation P441-PWY 4.2.1.11
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 4.2.1.11
glycolysis IV (plant cytosol) PWY-1042 4.2.1.11
formaldehyde assimilation I (serine pathway) PWY-1622 4.2.1.11
Entner-Doudoroff pathway III (semi-phosphorylative) PWY-2221 4.2.1.11
superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle PWY-5464 4.2.1.11
glycolysis II (from fructose 6-phosphate) PWY-5484 4.2.1.11
Rubisco shunt PWY-5723 4.2.1.11
gluconeogenesis II (Methanobacterium thermoautotrophicum) PWY-6142 4.2.1.11
Methanobacterium thermoautotrophicum biosynthetic metabolism PWY-6146 4.2.1.11
gluconeogenesis III PWY66-399 4.2.1.11
glycolysis VI (metazoan) PWY66-400 4.2.1.11
1-butanol autotrophic biosynthesis (engineered) PWY-6886 4.2.1.11
superpathway of glucose and xylose degradation PWY-6901 4.2.1.11
glycerol degradation to butanol PWY-7003 4.2.1.11
ethylene biosynthesis V (engineered) PWY-7124 4.2.1.11
photosynthetic 3-hydroxybutanoate biosynthesis (engineered) PWY-7218 4.2.1.11
superpathway of anaerobic sucrose degradation PWY-7345 4.2.1.11

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MGSSNLNINS KITDIFAYQV FDSRGVPTVA CVVKLASGHV GEAMVPSGAS TGEKEAIELR DNDPKNYFGK GVNEAVDNVN KVIAPKLIGL NAFDQLTVDQ AMIKLDNTPN KAKLGANAIL SVSLAVSKAA AKAQNSSLFQ YISNKLIGLN TTNFVLPVPM LNVINGGAHA DNYIDFQEFM IMPLGAKKMH EALKMASETF HALQNLLKKR GLNTNKGDEG GFAPNLKLAE DALDIMVEAI KLAGYKPWDD IAIAIDVAAS EFYDEDKKLY VFKKGIKANI LNAKDWSLTS KEMIAYLEKL TKKYPIISIE DGLSENDWEG MNQLTKTIGS HIQIVGDDTY CTNAELAKKG VAQNTTNSIL IKLNQIGSIS ETIQTIEVAK KANWSQVISH RSGETEDTTI ADLAVAAQTG QIKTGSMSRS ERIAKYNRLL YIEIELGDKG KYLGWNTFTN IKPKNFNI

NT Sequence
ATGGGAAGTT CAAATCTAAA CATCAATTCA AAAATAACCG ATATTTTTGC TTATCAAGTT TTTGATTCTC GGGGTGTTCC AACAGTAGCT TGTGTTGTTA AATTGGCATC TGGTCATGTA GGTGAAGCGA TGGTTCCATC AGGTGCTTCT ACAGGTGAGA AAGAAGCAAT TGAATTACGT GATAATGATC CAAAAAATTA TTTTGGTAAA GGCGTTAACG AAGCCGTTGA TAACGTTAAT AAAGTTATTG CCCCTAAGCT TATTGGCTTA AATGCATTTG ATCAATTAAC AGTGGATCAA GCAATGATTA AACTAGACAA TACTCCCAAC AAAGCAAAAT TAGGAGCAAA TGCTATATTA TCTGTTTCAC TTGCAGTATC AAAAGCAGCA GCAAAAGCAC AAAACAGCTC ATTATTTCAA TACATTTCAA ATAAATTAAT TGGATTAAAT ACAACAAATT TTGTTTTACC TGTGCCAATG TTAAATGTAA TTAATGGTGG TGCTCATGCT GATAACTATA TTGATTTTCA AGAGTTCATG ATCATGCCTT TAGGTGCTAA AAAGATGCAT GAAGCTTTAA AAATGGCTAG TGAAACTTTT CATGCTTTAC AAAATCTTTT AAAAAAGCGT GGATTAAACA CAAATAAAGG AGATGAAGGT GGATTTGCGC CTAACTTAAA ACTTGCAGAA GATGCACTTG ACATCATGGT TGAAGCCATT AAATTAGCTG GATATAAGCC TTGAGATGAT ATTGCTATTG CCATTGATGT TGCTGCTAGT GAGTTTTATG ACGAAGATAA AAAACTTTAT GTTTTCAAGA AAGGAATAAA AGCTAATATC CTTAATGCAA AGGATTGGAG TTTAACAAGC AAAGAAATGA TTGCTTACTT AGAAAAATTA ACAAAAAAAT ATCCAATTAT TTCAATAGAA GATGGTTTGA GTGAAAATGA TTGAGAAGGG ATGAACCAAT TAACTAAAAC CATAGGTAGC CATATTCAAA TTGTTGGTGA TGACACTTAC TGTACTAATG CAGAACTTGC TAAAAAAGGT GTTGCACAAA ATACAACAAA CTCGATATTG ATTAAATTAA ATCAAATTGG TTCTATTAGT GAAACGATTC AAACAATTGA AGTTGCAAAA AAAGCTAACT GGAGTCAAGT AATTTCACAT CGCAGTGGTG AAACAGAAGA TACAACTATT GCTGATTTGG CAGTTGCTGC CCAAACTGGT CAAATTAAAA CCGGTTCAAT GTCACGCTCA GAAAGAATAG CTAAATACAA TCGTTTGTTG TACATAGAAA TTGAACTTGG TGATAAAGGA AAATACTTAG GTTGAAATAC CTTTACAAAC ATTAAACCTA AAAACTTTAA CATC

© 2020 Seattle Children's Research Institute. All rights reserved.